Extracorporeal Membrane Oxygenation Machine Market

Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026

Report Code: MD 3966 Nov, 2021, by marketsandmarkets.com

[173 Pages Report] The global ECMO machine market is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9% from 2021 to 2026. The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of ECMO machines have played a key part in their adoption; their speed and accuracy, as well as quick processing times, allow for significantly higher patient screening volumes than earlier. This has pushed companies to focus on product development and innovation. However, these systems are priced at a premium, which slows their greater adoption. Other factors such as declining reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries, and potential risks associated with radiation exposure are also expected to hinder the growth of this market.

Extracorporeal Membrane Oxygenation Machine Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global ECMO machine market

The COVID-19 pandemic adversely affected the economy in 2020 and presented various challenges to clinical healthcare providers and patients across the globe. COVID-19 has also impacted various stages of the value chain, primarily due to strict lockdowns imposed by the governments of most countries. The turnaround time for the delivery of products and services has also been affected due to newer packaging protocols and lockdown measures imposed by countries. All these factors are negatively impacting the manufacturing and supply chain of digital X-ray systems.

However, COVID-19 has unleashed new opportunities for ECMO machine manufacturers and healthcare providers. In settings where laboratory testing (RT-PCR) is not available, or results are delayed or are initially negative, chest imaging has been considered as an alternative approach for patients with suspected or probable COVID-19. Imaging, including chest radiography, CT scans, and lung ultrasounds, has been considered to complement clinical evaluation and laboratory parameters in managing patients already diagnosed with COVID-19. According to the WHO, chest radiography can be helpful in the dynamic evaluation of COVID-19 pneumonia and its complications. Resolution or the progress of lung consolidation seen on a bedside chest radiograph can help caregivers make better therapeutic management decisions. Chest imaging can also inform the management of pneumothorax or pneumomediastinum.

ECMO Machine Market Dynamics

Driver: Growing adoption of ECMO in Lung Transplantation Prrocedures

The number of lung transplantation has increased in the last few decades, especially in the treatment of end stage lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease and Cystic Fibrosis.

Over the years, the adoption of ECMO machine in lung transplantation procedure has increased significantly in the management of patients with severe lung disease. The most common indication for the use of ECMO is Primary Graft Dysfunction (PGD) post lung transplantation. PGD is a syndrome consisting of lung injusry during the first 72 hours following lung transplant. With significant improvements in technologies, several studies have shown positive outcomes related to the use of ECMO as a bridging strategy as well as therapy for patients suffering from PGD, post transplant.

With the increasing prevalence of lung diseases across the globe, the use of ECMO is expected to rise further in the coming years.

Restraint: High cost of ECMO products

ECMO is an expensive therapy. Apart from the costs associated with the systems, other expenses include cost of staying at the hospital and the cost of additional disposable accessories. In addition to this, an entire team of medical professionals is required to take care of the patient undergoing an ECMO procedure, which adds to the cost of the treatment, although it differs depending upon the duration of its use. The average hospital stay for a patient with ECMO support is typicaly 1-2 weeks, however, it varies on the severity of the illness and can extend beyond this time frame. This increases the overall expense of the procedure which most patients can’t afford.

Opportunity: Increasing survival rates with ECMO

Survival rates of ECMO patients vary depending on the underlying condition and the patient’s age. VV-ECMO is indicated for patients with potentially reversible respiratory failure, including those with severe acute respiratory distress syndrome (ADRS), primary graft dysfunction post a lung transplant, and trauma to the lungs. Using VV-ECMO for respiratory failure patients increase their survival rates.

ECMO machines are also used for cardiac applications due to its ability to support failing cardiovascular systems with oxygenation functions. Using these systems for cardiac failures improve the survival rates for cardiac patients. Improving the survival rates with ECMO is expected to provide favourable growth opportunities for the ECMO market.

Challenge: Lack of Skilled Professionals

Lack of skilled professionals is one of the major challenges in the ECMO market. Despite the health sector employing millions of workers across the globe it continues to have low density health professionals according to a World Health Organization database.

ECMO Machine Market Ecosystem:

Extracorporeal Membrane Oxygenation Machine Market

Respiratory segment accounted for the largest share of global ECMO machine market in 2020

On the basis of applications, the ECMO machine market is segmented into respiratory, cardiac and ECPR applications. The respiratory segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the ECMO machine market. Moreover, the rising prevalence of lung diseases like tuberculosis, thoracic malignancies, osteoporosis, fractures, and CVDs increases the demand for medical imaging for diagnosis.

Arterio-Venous segment accounted for the largest market share of the ECMO machine market in 2020

On the basis of modality, the ECMO machine market is segmented into veno-arterio, veno-venous and arterio-venous. The arterio-venous segment accounted for the larger market share. The advantages associated with this segment, such as effective dynamic range, better medical evaluation, are contributing to the growth of this technology segment.

Increasing number of disorders/diseases in growing population resulting in an increase in the purchase of ECMO machines

On the basis of patient type, the ECMO machine market is segmented into neonates, pediatric and adults. The adult segment contributed to the largest share of global ECMO machine market in 2020. ECMO has been used for more than 40 years, and its benefits with neonates with respiratory distress are well recognized. The benefits of ECMO in adult patients with cardiac or respiratory failure are still debated, as ECMO was initially associated with low survival rates. However, recent technological advancements in ECMO circuits have led to a reduction in the rate of technical issues and complications.

Extracorporeal Membrane Oxygenation Machine Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Controllers, by component, have contributed the largest share in the ECMO machine market

Based on component, the global ECMO machine market is segmented into pumps, oxygenators, controllers, cannula and accessories. The controllers segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of the systems among end users due to their lowercost compared to others.

Portable ECMO machine Segment, by product type, has commanded the highest growth rate in the forecast period

Based on product type, the ECMO machine market is segmented into Static ECMO machines and Portable ECMO machines. Portable ECMO machine segment is expected to dominate the market during the forecast period. Portable ECMO machines can be transported to any desired location and they are light in weight. These systems are especially used in a variety of imaging-set ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient’s beside for critically ill patients or patients with mobility challenges.

The APAC market, by region, to register highest growth rate in the forecast period

The  ECMO Machine market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The asia-pacific market is expected to register the highest growth in the forecast period. Growth in the ECMO machine market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.

Key Market Players

The ECMO machine market is dominated by Getinge Group (Sweden), Medtronic plc (US), Fresenius  Medicalcare AG & Co. KGAA (Germany), Microport (China), and Terumo Cardiovascular Systems Corporation (Japan). The other leading market players include Livanova plc (UK), Nipro Corporation (Japan), Eurosets S.R.L. (Italy), Origin Biomedical (US), Cytosorbents Corporation (Australia), and Abiomed (US).

Fresenius Medical Care AG & Co. KGaA is one of the leading providers of ECMO products and services to patients. The company operates through two business divisions- Healthcare Services and Healthcare Products. The Healthcare Products division includes two major segments, namely, Dialysis Products ad Non-Dialysis Products. It focuses on inorganic and organic growth strategies, including new product launches, partnerships, and agreements, to enhance and maintain its position in the market. The company has launched various products in the ECMO machine market in the last three years and is constantly engaged in R&D for product innovation. The company has a wide geographic presence in Europe, Africa, the Middle East, Asia, Australia, and the US, and is constantly engaged in strategic deals and partnerships to promote growth in the market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2018–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD million)

Segments covered

Patient Type, Application, Modality Outlook, Product, Component, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

The dominant players in the global ECMO machine market are Fresenius Medical care AG & Co. KGaA (Germany), Getinge Group (Sweden), Medtronic plc (US) among others

In this report, the ECMO machine market is segmented based on Patient Type, Application, Modality Outlook, Product, Component, and Region.

Global ECMO machine market, by Product

  • ECMO Machines
    • Portable Devices
    • Static Devices
  • Software

Global ECMO machine market, by Component

  • Pumps
  • Oxygenators
  • Controllers
  • Cannul
  • Assessories

Global ECMO machine market, by Modality Outlook

  • Veno-Venous
  • Veno-Arterials
  • Arterio-Venous

Global ECMO machine market, by Portability

  • Neonates
    • Neonates
    • Pediatrics
    • Adults
  • Pediatrics
    • Neonates
    • Pediatrics
    • Adults
  • Adults
    • Neonates
    • Pediatrics
    • Adults

Global ECMO machine market, by Patient Type

  • Neonates
  • Pediatrics
  • Adults

Global ECMO machine market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
    • Middle East & Africa

Recent Developments

  • In February 2020, Fresenius Medical care AG & Co. KGaA (Germany) received US FDA clearance Novalung, a heart and lung support system for the treatment of acute respiratory or cardiopulmonary failure
  • In July 2021, Xenios AG(Germany) received  received approval from the National Medical Products Administration (NMPA) in China for the Xenios Console and patient kits for ECMO therapy.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKETS SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 KEY MARKET STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 23)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION METHODOLOGY
    2.3 MARKET DATA VALIDATION AND TRIANGULATION
    2.4 KEY RESEARCH ASSUMPTIONS
    2.5 LIMITATIONS
           2.5.1 METHODOLOGY-RELATED LIMITATIONS
    2.6 RISK ASSESSMENT
    2.7 GROWTH RATE ASSUMPTIONS
    2.8 COVID-19 HEALTH ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
    2.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO

3 EXECUTIVE SUMMARY (Page No. - 33)

4 PREMIUM INSIGHTS (Page No. - 36)
    4.1 ECMO MARKET OVERVIEW
    4.2 ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020)
    4.3 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    4.4 ECMO MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. - 42)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
                    5.2.1.2 Growing adoption of ECMO in lung transplantation procedures
                    5.2.1.3 Growth in the number of ECMO centers
                    5.2.1.4 Technological advancements in ECMO machines
           5.2.2 RESTRAINTS
                    5.2.2.1 Complications associated with ECMO
                    5.2.2.2 High cost of ECMO procedures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing survival rates with ECMO
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of skilled professionals
                    5.2.4.2 Eligibility issues for ECMO
                    5.2.4.3 Issues related to selecting the right equipment
                    5.2.4.4 Risks related to the transport of ECMO patients
                    5.2.4.5 Issues related to treatment decision-making
    5.3 REGULATORY LANDSCAPE
           5.3.1 NORTH AMERICA
                    5.3.1.1 US
                    5.3.1.2 Canada
           5.3.2 EUROPE
           5.3.3 ASIA PACIFIC
                    5.3.3.1 India
                    5.3.3.2 Japan
                    5.3.3.3 China
    5.4 COVID-19 IMPACT ON THE ECMO MARKET
           5.4.1 REIMBURSEMENT SCENARIO
    5.5 PATENT ANALYSIS
           5.5.1 PATENTS GRANTED FOR ECMO MACHINES
           5.5.2 PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES
    5.6 VALUE CHAIN ANALYSIS
    5.7 PRICING TREND ANALYSIS
    5.8 PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 ECOSYSTEM LANDSCAPE

6 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT (Page No. - 60)
    6.1 INTRODUCTION
    6.2 ECMO MACHINES
           6.2.1 STATIC ECMO MACHINES SEGMENT TO DOMINATE THE ECMO MACHINES MARKET
           6.2.2 PORTABLE ECMO MACHINES
           6.2.3 STATIC ECMO MACHINES
    6.3 SOFTWARE
           6.3.1 SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING THE FORECAST PERIOD

7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT (Page No. - 69)
    7.1 INTRODUCTION
    7.2 PUMPS
           7.2.1 CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT
    7.3 OXYGENATORS
           7.3.1 PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME
    7.4 CONTROLLERS
           7.4.1 CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED
    7.5 CANNULAS
           7.5.1 THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES
    7.6 ACCESSORIES

8 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY (Page No. - 75)
    8.1 INTRODUCTION
    8.2 VENOARTERIAL ECMO
           8.2.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    8.3 VENOVENOUS ECMO
           8.3.1 VENOVENOUS ECMO IS USED WHEN ADEQUATE HEART FUNCTION IS AVAILABLE
    8.4 ARTERIOVENOUS ECMO
           8.4.1 ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE

9 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE (Page No. - 79)
    9.1 INTRODUCTION
    9.2 NEONATES
           9.2.1 A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE
    9.3 PEDIATRIC PATIENTS
           9.3.1 PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES
    9.4 ADULTS
           9.4.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE OF ECMO IN ADULT PATIENTS

10 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION (Page No. - 83)
     10.1 INTRODUCTION
     10.2 RESPIRATORY APPLICATIONS
             10.2.1 RESPIRATORY APPLICATIONS FOR NEONATES
             10.2.2 RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS
             10.2.3 RESPIRATORY APPLICATIONS FOR ADULTS
     10.3 CARDIAC APPLICATIONS
             10.3.1 CARDIAC APPLICATIONS FOR ADULTS
             10.3.2 CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS
             10.3.3 CARDIAC APPLICATIONS FOR NEONATES
             10.3.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
             10.3.5 ECPR APPLICATIONS FOR ADULTS
             10.3.6 ECPR APPLICATIONS FOR PEDIATRIC PATIENTS
     10.4 NEONATES

11 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION (Page No. - 90)
     11.1 INTRODUCTION
     11.2 NORTH AMERICA
             11.2.1 US
                        11.2.1.1 US accounted for the largest share of the North American market
             11.2.2 CANADA
                        11.2.2.1 Implementation of the ABF model in Canadian hospitals to drive market growth
     11.3 EUROPE
             11.3.1 GERMANY
                        11.3.1.1 Increasing volume of ECMO procedures to drive market growth in Germany
             11.3.2 FRANCE
                        11.3.2.1 Rising healthcare spending to drive market growth in France
             11.3.3 UK
                        11.3.3.1 Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK
             11.3.4 ITALY
                        11.3.4.1 High burden of CVDs contributing to the growth of the ECMO market in Italy
             11.3.5 SPAIN
                        11.3.5.1 High adoption of advanced technologies to drive market growth in Spain
     11.4 REST OF EUROPE
     11.5 ASIA PACIFIC
             11.5.1 JAPAN
                        11.5.1.1 Favorable healthcare infrastructure in Japan to drive market growth
             11.5.2 CHINA
                        11.5.2.1 Rising geriatric population and increasing prevalence of CVD to drive market growth in China
             11.5.3 INDIA
                        11.5.3.1 Growing applications and rising adoption of ECMO to drive market growth in India
             11.5.4 AUSTRALIA
                        11.5.4.1 Technological advancements to drive market growth in Australia
             11.5.5 SOUTH KOREA
                        11.5.5.1 Increasing incidence of cardiac disorders to drive market growth in South Korea
             11.5.6 REST OF APAC
     11.6 LATIN AMERICA
             11.6.1 BRAZIL
                        11.6.1.1 Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil
             11.6.2 MEXICO
                        11.6.2.1 High burden of CVDs in the country to drive market growth in Mexico
             11.6.3 REST OF LATIN AMERICA
             11.6.4 MIDDLE EAST & AFRICA
                        11.6.4.1 Increasing prevalence of target diseases to drive market growth in the Middle East & Africa

12 COMPETITIVE LANDSCAPE (Page No. - 118)
     12.1 INTRODUCTION
     12.2 REVENUE SHARE ANALYSIS
     12.3 MARKET SHARE ANALYSIS
     12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
             12.4.1 TERMINOLOGY/NOMENCLATURE
                        12.4.1.1 Stars
                        12.4.1.2 Emerging leaders
                        12.4.1.3 Pervasive players
                        12.4.1.4 Participants
     12.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020)
             12.5.1 PROGRESSIVE COMPANIES
             12.5.2 RESPONSIVE COMPANIES
             12.5.3 DYNAMIC COMPANIES
             12.5.4 STARTING BLOCKS
     12.6 COMPETITIVE BENCHMARKING
     12.7 COMPETITIVE SCENARIO (2018–2021)
             12.7.1 NEW PRODUCT LAUNCHES & APPROVALS

13 COMPANY PROFILES (Page No. - 131)
     13.1 KEY PLAYERS
             13.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
                        13.1.1.1 Business overview
                        13.1.1.2 Products offered
                        13.1.1.3 Recent developments
                        13.1.1.4 MnM view
             13.1.2 GETINGE GROUP
                        13.1.2.1 Business overview
                        13.1.2.2 Products offered
                        13.1.2.3 MnM view
             13.1.3 MEDTRONIC PLC
                        13.1.3.1 Business overview
                        13.1.3.2 Products offered
                        13.1.3.3 MnM view
             13.1.4 MICROPORT
                        13.1.4.1 Business overview
                        13.1.4.2 Products offered
             13.1.5 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
                        13.1.5.1 Business overview
                        13.1.5.2 Products offered
                        13.1.5.3 MnM view
             13.1.6 NIPRO CORPORATION
                        13.1.6.1 Business overview
                        13.1.6.2 Products offered
             13.1.7 LIVANOVA PLC
                        13.1.7.1 Business overview
                        13.1.7.2 Products offered
             13.1.8 EUROSETS S.R.L.
                        13.1.8.1 Business overview
                        13.1.8.2 Products offered
             13.1.9 ORIGEN BIOMEDICAL, INC.
                        13.1.9.1 Business overview
                        13.1.9.2 Products offered
             13.1.10 CYTOSORBENTS CORPORATION
                        13.1.10.1 Business overview
                        13.1.10.2 Products offered
             13.1.11 ABIOMED
                        13.1.11.1 Business overview
                        13.1.11.2 Products offered
             13.1.12 BRAILE BIOMΙDICA
                        13.1.12.1 Business overview
                        13.1.12.2 Products offered
             13.1.13 SPECTRUM MEDICAL
                        13.1.13.1 Business overview
                        13.1.13.2 Products offered
             13.1.14 HAEMONETICS
                        13.1.14.1 Business overview
                        13.1.14.2 Products offered
             13.1.15 XENIOS AG
                        13.1.15.1 Business overview
             13.1.16 PRODUCTS OFFERED
                        13.1.16.1 Recent developments
             13.1.17 KANEKA CORPORATION
                        13.1.17.1 Business overview
                        13.1.17.2 Products offered
             13.1.18 SB-KAWASUMI LABORATORIES, INC.
                        13.1.18.1 Business overview
                        13.1.18.2 Products offered
             13.1.19 WEIGAO GROUP
                        13.1.19.1 Business overview
                        13.1.19.2 Products offered
                        13.1.19.3 Zhengyuan Technology
             13.1.20 BUSINESS OVERVIEW
                        13.1.20.1 Products offered
             13.1.21 BREETHE, INC.
                        13.1.21.1 Business overview
                        13.1.21.2 Products offered

14 APPENDIX (Page No. - 131)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS


LIST OF TABLES (171 Tables)

TABLE 1 RISK ASSESSMENT: ECMO MARKET
TABLE 2 NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019
TABLE 3 GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS
TABLE 4 AVERAGE COST OF ECMO IN VARIOUS COUNTRIES
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE ECMO MARKET
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
TABLE 8 NMPA MEDICAL DEVICE CLASSIFICATION
TABLE 9 PATENTS GRANTED FROM 2016 TO 2021
TABLE 10 FILED PATENTS, 2000–2021
TABLE 11 RANTED PATENTS, 2010–2021
TABLE 12 PUBLISHED PATENTS, 2016–2021
TABLE 13 AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD)
TABLE 14 ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 15 ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 16 ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 17 ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 18 ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 19 ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 20 ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 21 ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 22 PORTABLE ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 23 PORTABLE ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 24 PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 25 PORTABLE ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 26 STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 27 STATIC ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 28 STATIC ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 29 STATIC ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 30 STATIC ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 31 ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 32 ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 33 ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 34 ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 35 ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 36 ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION)
TABLE 37 ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION)
TABLE 38 ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION)
TABLE 39 ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION)
TABLE 40 ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION)
TABLE 41 ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 42 VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 43 VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 44 ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 45 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS, AND ADULTS
TABLE 46 ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 47 ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION)
TABLE 48 ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018–2026 (USD MILLION)
TABLE 49 ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION)
TABLE 50 ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 51 ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
TABLE 52 NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 53 NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 54 NUMBER OF ADULTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
TABLE 55 ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
TABLE 56 ECMO MARKET FOR ECPR APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
TABLE 57 ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 59 NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 60 NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 61 NORTH AMERICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 62 NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 65 US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 66 US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 67 CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 68 CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 69 EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 70 EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 71 EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 72 EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 73 EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 74 EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 75 EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 76 GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 77 GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 78 FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 79 FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 80 UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 81 UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 82 ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 83 ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 84 SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 85 SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 86 REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 87 REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 88 ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 89 ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 90 ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 91 ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 93 ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 95 JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 96 JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 97 CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 98 CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 99 INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 100 INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 101 AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 102 AUSTRALIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 103 SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 104 SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 105 REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 106 REST OF APAC: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 107 LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 108 LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 109 LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 110 LATIN AMERICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 111 LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 112 LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 113 LATIN AMERICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 114 BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 115 BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 116 MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 117 MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 118 REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 119 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 125 MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
TABLE 127 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
TABLE 128 COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET
TABLE 129 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
TABLE 130 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS
TABLE 131 PRODUCT LAUNCHES
TABLE 132 GETINGE GROUP: BUSINESS OVERVIEW
TABLE 133 GETINGE GROUP: PRODUCT OFFERINGS
TABLE 134 MEDTRONIC PLC: BUSINESS OVERVIEW
TABLE 135 MEDTRONIC PLC: PRODUCT OFFERINGS
TABLE 136 MICROPORT: BUSINESS OVERVIEW
TABLE 137 MICROPORT: PRODUCT OFFERINGS
TABLE 138 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW
TABLE 139 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS
TABLE 140 NIPRO CORPORATION: BUSINESS OVERVIEW
TABLE 141 NIPRO CORPORATION: PRODUCT OFFERINGS
TABLE 142 LIVANOVA PLC.: BUSINESS OVERVIEW
TABLE 143 LIVANOVA PLC.: BUSINESS OVERVIEW
TABLE 144 LIVANOVA PLC: PRODUCT OFFERINGS
TABLE 145 EUROSETS S.R.L.: BUSINESS OVERVIEW
TABLE 146 EUROSETS S.R.L.: PRODUCT OFFERINGS
TABLE 147 ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW
TABLE 148 ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS
TABLE 149 CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW
TABLE 150 CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS
TABLE 151 ABIOMED: BUSINESS OVERVIEW
TABLE 152 ABIOMED: PRODUCT OFFERINGS
TABLE 153 BRAILE BIOMΙDICA: BUSINESS OVERVIEW
TABLE 154 BRAILE BIOMΙDICA: PRODUCT OFFERINGS
TABLE 155 SPECTRUM MEDICAL: BUSINESS OVERVIEW
TABLE 156 SPECTRUM MEDICAL: PRODUCT OFFERINGS
TABLE 157 HAEMONETICS: BUSINESS OVERVIEW
TABLE 158 HAEMONETICS: PRODUCT OFFERINGS
TABLE 159 XENIOS AG: BUSINESS OVERVIEW
TABLE 160 XENIOS AG: PRODUCT OFFERINGS
TABLE 161 PRODUCT LAUNCHES
TABLE 162 KANEKA CORPORATION: BUSINESS OVERVIEW
TABLE 163 KANEKA CORPORATION: PRODUCT OFFERINGS
TABLE 164 SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW
TABLE 165 SB-KAWASUMI: PRODUCT OFFERINGS
TABLE 166 WEIGAO GROUP: BUSINESS OVERVIEW
TABLE 167 WEIGAO GROUP: PRODUCT OFFERINGS
TABLE 168 ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW
TABLE 169 ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS
TABLE 170 BREETHE, INC.: BUSINESS OVERVIEW
TABLE 171 BREETHE, INC.: PRODUCT OFFERINGS


LIST OF FIGURES (37 Figures)

FIGURE 1 ECMO MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 4 DATA TRIANGULATION METHODOLOGY
FIGURE 5 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 6 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022)
FIGURE 7 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 8 ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026
FIGURE 9 ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET
FIGURE 11 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
FIGURE 12 NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020
FIGURE 13 ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE THE ECMO MARKET DURING THE FORECAST PERIOD
FIGURE 14 EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS
FIGURE 15 ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 VALUE CHAIN OF THE ECMO MARKET
FIGURE 17 THREAT OF NEW ENTRANTS
FIGURE 18 THREAT OF SUBSTITUTES
FIGURE 19 BARGAINING POWER OF SUPPLIERS
FIGURE 20 BARGAINING POWER OF BUYERS
FIGURE 21 INTENSITY OF COMPETITIVE RIVALRY
FIGURE 22 ECMO MARKET: ECOSYSTEM LANDSCAPE
FIGURE 23 NORTH AMERICA: ECMO MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: ECMO MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET, 2018–2021
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
FIGURE 27 ECMO MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 28 ECMO MARKET: DEGREE OF COMPETITION
FIGURE 29 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
FIGURE 30 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2020
FIGURE 31 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
FIGURE 32 GETINGE GROUP: COMPANY SNAPSHOT
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 34 MICROPORT: COMPANY SNAPSHOT
FIGURE 35 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT
FIGURE 36 NIPRO CORPORATION: COMPANY SNAPSHOT
FIGURE 37 LIVANOVA PLC.: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ECMO machine market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global ECMO machie market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as CROs, hospitals, transplant centers, healthcare service providers, commercial service providers, academia, and research organizations) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 20% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 80%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Extracorporeal Membrane Oxygenation Machine Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

The top-down and bottom-up approaches were used to estimate and validate the sizes of the global market and various other dependent submarkets of the ECMO machine market. The research methodology used to estimate the market size includes the following details:

  • The key players in the market were identified through secondary research, and their market contributions in respective regions were determined through primary and secondary research.
  • This entire procedure included the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives.
  • All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources.
  • All the possible parameters affecting the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to reach the final quantitative and qualitative data.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in the report.

Extracorporeal Membrane Oxygenation Machine Market Size, and Share

Data Triangulation:

After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both demand and supply sides. Along with this, the market was validated using both top-down and bottom-up approaches.

Report Objectives:

  • To define, describe, and forecast the global ECMO machine market on the basis of patient type, application, component, modality outlook, product and region
  • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of market segments with respect to five key regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To track and analyze competitive developments such as new product launches, agreements & partnerships, acquisitions, and research & development activities in the ECMO machine market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global ECMO machine market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe ECMO machine market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
  • Further breakdown of the Rest of Asia Pacific ECMO machine market into New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
  • Further breakdown of the Latin American ECMO machine market into Argentina, Chile, Peru, and Colombia, among other
COVID-19

Get in-depth analysis of the COVID-19 impact on the Extracorporeal Membrane Oxygenation Machine Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Extracorporeal Membrane Oxygenation Machine Market

Request For Special Pricing
Report Code
MD 3966
Published ON
Nov, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Extracorporeal Membrane Oxygenation Machine Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved